Project Number GC-2012728 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2015 View Full Project Details for Drug development and optimization of compounds stabilizing ryanodine calcium channels for AD Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) m. Synaptic Plasticity/Neuroprotection Researcher and Organization Principal Investigator STUTZMANN, GRACE Principal Investigator First Name GRACE Principal Investigator Last Name STUTZMANN Awardee Organization RFUMS/Chicago Medical School Awardee State Illinios Contact PI Country United States Project Detail Funding Opportunity Announcement Preclinical RFP FY Overall Cost $257,942 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
